Search
for
Sort by
Research 181–210 of 1000+
- 4. Bullous/Mucous Membrane
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Treatment of invasive aspergillosis with itraconazole
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Prospect of Stem Cell Conditioned Medium in Regenerative Medicine
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Biomaterials Functionalized with MSC Secreted Extracellular Vesicles and Soluble Factors for Tissue Regeneration
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Dermatoses of pregnancy
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- COVID-19 and Sex Differences
- Cutaneous signs in COVID ‐19 patients: A review
- Cutaneous complications of chemotherapeutic agents
- Endocrinology of Transgender Medicine
- Testosterone therapy for transgender men
- Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
- Hormone therapy for transgender patients
- Physiologic skin changes in pregnancy
- Ancient-modern concordance in Ayurvedic plants: some examples.
- Macrophages Regulate Schwann Cell Maturation after Nerve Injury
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Cutaneous manifestations of systemic lupus erythematosus
- Histopathology of non-scarring alopecia
- Drug-Induced Skin, Nail and Hair Disorders
- Cutaneous reactions to recombinant cytokine therapy
- Biocomposite nanofiber matrices to support ECM remodeling by human dermal progenitors and enhanced wound closure